tiprankstipranks
Dyne Therapeutics Welcomes John Cox as New CEO and Board Member
PremiumCompany AnnouncementsDyne Therapeutics Welcomes John Cox as New CEO and Board Member
1M ago
Dyne Therapeutics CEO Joshua Brumm to step down, John Cox to succeed
PremiumThe Fly
Dyne Therapeutics CEO Joshua Brumm to step down, John Cox to succeed
1M ago
Dyne Therapeutics Announces CEO Transition
PremiumPress Releases
Dyne Therapeutics Announces CEO Transition
1M ago
Dyne Therapeutics price target raised to $41 from $35 at Stifel
PremiumThe FlyDyne Therapeutics price target raised to $41 from $35 at Stifel
2M ago
Dyne Therapeutics files automatic mixed securities shelf
PremiumThe Fly
Dyne Therapeutics files automatic mixed securities shelf
2M ago
Dyne Therapeutics price target raised to $47 from $44 at Oppenheimer
PremiumThe Fly
Dyne Therapeutics price target raised to $47 from $44 at Oppenheimer
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100